EP2517584A1 - Composite filter comprising biological composition - Google Patents

Composite filter comprising biological composition Download PDF

Info

Publication number
EP2517584A1
EP2517584A1 EP20100838536 EP10838536A EP2517584A1 EP 2517584 A1 EP2517584 A1 EP 2517584A1 EP 20100838536 EP20100838536 EP 20100838536 EP 10838536 A EP10838536 A EP 10838536A EP 2517584 A1 EP2517584 A1 EP 2517584A1
Authority
EP
European Patent Office
Prior art keywords
biological composition
composite filter
carrier
tow
filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20100838536
Other languages
German (de)
French (fr)
Other versions
EP2517584A4 (en
EP2517584B1 (en
Inventor
Fengcheng Shi
Lijun Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Tobacco Chuanyu Industrial Co Ltd
Original Assignee
China Tobacco Chuanyu Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN2009102635484A priority Critical patent/CN101708072B/en
Application filed by China Tobacco Chuanyu Industrial Co Ltd filed Critical China Tobacco Chuanyu Industrial Co Ltd
Priority to PCT/CN2010/071732 priority patent/WO2011075970A1/en
Publication of EP2517584A1 publication Critical patent/EP2517584A1/en
Publication of EP2517584A4 publication Critical patent/EP2517584A4/en
Application granted granted Critical
Publication of EP2517584B1 publication Critical patent/EP2517584B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/14Use of materials for tobacco smoke filters of organic materials as additive
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters

Abstract

This invention involves a type of composite filter tips, which contains biological composition adhering to the carrier that is added to the tow filter rod when the rod is made. The biological composition consists of cobalt porphyrin and ginkgo leaf extract, and the mass ratio of the former to the latter is 1:1~80. Such filter tip can not only reduce releasing quantity of harmful ingredients such as free radical, benzopyrene [a] and tobacco specific nitrosamine in smoke, but also make acute toxicity, subchronic toxicity, cytotoxicity and mutagenicity lower than those of the control group. In addition, no adverse impact is imposed on smoking quality of the cigarette.

Description

    Technical Field
  • This invention involves a type of composite filter tips containing biological composition, more specifically, the application of biological composition composed of cobalt porphyrin and ginkgo leak extract to the filter tip, which belongs to the processing technology of filter tip additive and filter tip.
  • Background Art
  • The filter tip is used for filtering the harmful substances in smoke, with the tar removal rate of about 35%. The existing fiber filter rod consists mainly of either acetate tow or polypropylene tow, and its filtration efficiency depends on molecular structure and physicochemical properties. The above-mentioned two materials, limited by the structure and physicochemical properties, have defects in filtration efficiency. The acetate tow carries negative charge, while lots of particles in smoke (about 2×109 negative charge particles per 1ml smoke) also carry the negative charge. As the same charges repel each other, such filter tip removes particulate matter in smoke by means of mechanical restriction and diffusion deposition; as a result of no active group, part polar structure in the tow has a certain affinity for only the highly polar matters containing oxygen atoms, such as aldehyde ketone and lactone (carboxyl compounds) as well as furan and phenolic compound (heterocyclic compounds), and thus filters selectively the matters. However, the acetate tow has a low absorbing capacity for harmful carbon radical, aromatic hydrocarbon, propylene (lowly polar compound) and trace metal element in the smoke. Furthermore, the polypropylene tow is a high molecular saturated alkane compound and free from the negative charge group; its molecular structure is stable, and its physicochemical properties are inert; its hydrophobic group is of the nonpolar structure, and there is no polar structure with a strong affinity for polar smoke components; change of pressure drop will not impact on selective filtration of the polar smoke components. Accordingly, the polypropylene tow has low remove efficiency for polar components and low-boiling spicy miscellaneous gas molecules in the smoke.
  • It is well known that the smoke contains many harmful ingredients, especially possibly cancerogenic free radical, condensed aromatics and tobacco specific nitrosamine, all of which cannot be removed effectively by the above traditional filter tips.
  • To this end, a type of filter tips with strengthened functions is needed. Adding the composition to filter tip aims to not only remove selectively the harmful ingredients in smoke, but also make the harmless flavor components in smoke pass smoothly the filter tip. In addition, such new filter tip also requires convenient production, low production cost and easy realization of industrialization.
  • The porphyrins are of unique structure. Specifically, its molecule is rigid and has large face; position and direction of its edge functional group can be controlled so that molecular size, molecularity, functional group and chiral isomer can be identified effectively. At present, the porphyrins have been applied in chromatographic fractionation analysis, sensor, artificial enzyme analysis and receptor building in the field of analytical chemistry. For chromatographic analysis, stationary phase of porphyrin derivatives has been successfully applied in HPLC and CE etc. Kibbey etc. (Kibbey CE, Meyerhoff ME.Anal Chem,1993,65(17): 2189-2196.) synthesized for the first time the stationary phase of porphyrins, such as H2CPTPP, SnCPTPP and InCPTPP, which was used successfully for separation of PAHs. Then ProP-silica stationary phase (Xiao J, Kibbey CE, Coutant DE, et al. J Liq Chromatogr Rel Technol, 1996, 19:2901- 2932.) and MProP-silica stationary phase (Chen S, Meyerhoff ME.Anal Chem, 1998, 70(13): 2523- 2529.) were prepared to obtain better selectivity of molecular shape. Those stationary phases, more stable than stationary phase of fibers, are used for research of pre-enrichment carcinogenicity PAHs. The principle of good identifiability of PAHs by porphyrins is that PAHs rich in π electrons has strong π-π interaction with porphyrins. Such interaction has not only the face-to-face π-π interaction but also the face-to-edge one (Chen S, Fetzer JC, Meyerhoff ME. Fresenius J Anal Chem, 2001(3-4):385-392.Yutaka S, Masaki M,Junichi O,et al.Anal Sci,1991, 7(5):805-806. Mifune M, Shimomura Y, Saito Y, et al.Bull Chem Soc Jpn,1998,71(8): 1825- 1829.).
  • As Chinese herbal medicine, the ginkgo leaf extract has been used for thousands of years in China. The internationally recognized ginkgo leaf extract contains over 24% flavonoid and over 6% lactone. The research shows that the main active constituent with antioxidative effect in ginkgo leaf extract is the flavonoid and the lactone has no obvious antioxidative effect (Mou Lingli etc., Chemical Constituents in Ginkgo Leaf and Their Antioxidative Activity, Chinese Journal of Natural Medicines, 2008, 6(1): 26-29.), and that the reductive hydroxyl (-OH) functional group in the molecule can play a direct role in antioxidative effect. Quercetin in flavonoid, serving as a hydrogen atom donor, can interdict and terminate the free radical chain reaction, remove directly free radicals and hydrogen peroxide, antagonize effectively the destroy of free radicals on unsaturated fatty acid, reduce content of lipidic peroxide, and enhance activity of the superoxide dismutase (Li Yuhua etc., Action of Ginkgo Leaf Extract [J]. Chinese Health Care, 2008, 16(11):529.).
  • The chemiluminescent method determines the O2· removal effect by flavonoid. The research on relations between its structure and O2· removal activity proves that 4'-OH and 2, 3 double bond are the main activity parts of removing O2· (Zou Yaohong etc., The Research on Property of Flavonoid to Remove Active Oxygen Free Radical [J]. Journal of Changshu College, 2001, 15(2):47-50.), and that 3', 4'- ortho dihydroxyl is the key structure of removing activity of free radicals while hydroxyls on the rest positions also play a role (Hu Chun etc., Research with Chemiluminescent Method on O2· and ·OH Removal by Flavonoid, Journal of Wuxi University of Light Industry, 1996, 15(3):194-198.).
  • Structural factors of flavonoids for antioxidative activity are researched by the semi-empirical calculation methods of structural chemistry and quantum chemistry, and the relative results are described in the following. ① The energy △ HOF required for forming semiquinone free radicals within molecule is low, and the free radical formed is stable, thus the antioxidative activity is strong. ② Uniform distribution of electron spin density is crucial for strong antioxidative activity. For the semiquinone free radical formed by flavone containing ortho-diphenol- hydroxyl, electron spin density is distributed evenly, and semiquinone group in molecule and hydrogen bond in molecule shaped by ortho phenolic hydroxyl make the system energy level decrease, so the antioxidative activity of flavonoid containing ortho-diphenol- hydroxyl is better than that containing metadiphenol- hydroxyl. ③ Amount of phenolic hydroxyl in molecule and that of intramolecular H-bond are in positive correlation with antioxidative activity of the molecule, which contributes to an important factor of strong antioxidative activity of the flavonoid. (Zhao Jihong etc., Structural Factors of Flavonoids for Antioxidative Activity, Journal of North China University of Technology, 2001,13(1):36-44.) Antioxidative activity of flavonoids can be improved by means of changing hydroxyl substitute, making distribution of electron spin density for semiquinone free radical more uniform, increasing the amount of phenolic hydroxyl in flavonoids and of intramolecular hydrogen bonds by chemical modification.
  • The porphyrins with unique structure are characterized by good selectivity and separating property when condensed aromatics and Fuller hydrocarbon etc. are determined by solid phase of HPLC; the ginkgo leaf extract has good antioxidative activity. Therefore, the composition of porphyrins and ginkgo leaf extract, if used in the filter tip, can remove effectively the harmful ingredients, and thus the filter tip with strengthened functions comes into being.
  • Contents of the Invention
  • This invention aims to provide a type of filter tips with high removal efficiency of harmful substances in smoke, so as to reduce smoking harm on human body.
  • As for the invented filter tip, the carrier adhering to the biological composition is added to the tow filter rod to make the composite filter tip. The biological composition is composed of cobalt porphyrin and ginkgo leak extract.
  • This invention includes the following:
    1. A type of composite filter tips containing biological composition, which contains a biological composition adhering to the carrier, and which is added to the tow filter rod when the rod is made.
    2. In detail: it is the dual composite filter which is made from the tow filter rod with biological composition and that without biological composition.
    3. In detail: the biological composition consists of cobalt porphyrin and ginkgo leaf extract.
    4. In detail: the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1~80; ratio of mass of the biological composition to the carrier is 0.1‰~5.0‰; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
    5. In detail: the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1~50.
    6. In detail: the mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1~10.
    7. The methods of preparing the composite filter tip containing biological composition, including the following steps:
  1. (1) The biological composition of cobalt porphyrin and ginkgo leak extract is prepared and then dissolved in ethanol. In addition, the polyvinylpyrrolidone is added to the ethanol solution containing biological composition and mixed up.
  2. (2) The mixture in Step (1) adheres to the carrier.
  3. (3) The carrier in Step (2) is added evenly when tow filter rod is made.
  4. (4) Then the tow filter rod with the composition and one without the composition are rolled with the inner coil paper respectively.
  5. (5) Finally, tow filter rods are made into the filter tip with outer coil paper on the composite filter tip maker.

8. Application of the above composite filter tip containing biological composition to the cigarette The relative tests in the following:
a. Interaction of cobalt porphyrin and 3, 4-benzopyrene [a] is determined by fluorescence quenching method.
Polycyclic aromatic hydrocarbon always has characteristic photoluminescence excitation spectrum and fluorescence emission spectrum, so the interaction of cobalt porphyrin and 3, 4-benzopyrene [a] is determined by fluorescence quenching method. The result shows that, with the increase of cobalt porphyrin concentration, fluorescence intensity of 3, 4-benzopyrene [a] decreases, and fluorescence spectrum has red shift (see Attached Figure 1), which proves that 3, 4-benzopyrene [a] and cobalt porphyrin interact.
b. Interaction of cobalt porphyrin and tobacco specific nitrosamine is determined by ultraviolet spectrophotometry.
The porphyrins have the characteristic of ultraviolet absorption and characteristic absorption peak near 413nm, so the interaction of cobalt porphyrin and tobacco specific nitrosamine (TSNAs, NNN, NAB, NNK, NAT) is determined by ultraviolet spectrophotometry. The result shows that intensity of characteristic absorption peak (413nm) of porphyrins decreases after TSNAs is added, and the intensity will decrease gradually along with increasing concentration of TSNAs; new composite characteristic peak (438nm) appears and its intensity increases gradually along with increasing concentration of TSNAs; ultraviolet spectrum has red shift (see the Attached Figure 2); the binding constant (K) with NNN, NAB, NNK and NAT is 1.4×104, 1.1×104, 5.8×103 and 3.4×103 respectively, and order of the binding capacity is NNN, NAB, NNK and NAT. The above proves that porphyrin and TSNAs generate a new composition and interact strongly.
c. The release of free radical, 3, 4-benzopyrene [a] and tobacco specific nitrosamine in smoke is determined.
For the blank control cigarette and the cigarette with the invented filter tip, releasing quantity of free radical, 3, 4-benzopyrene [a] and tobacco specific nitrosamine in smoke is determined, and filtration efficiency is calculated, see Table 1. According to the table, harmful ingredients in smoke of cigarette with the invented filter tip, compared with those in the blank control cigarette, reduce by 30.36%~66.89%. Table 1 Determination Results and Filtration Efficiency of Harmful Ingredients in Smoke
Gas-phase free radical (relative unit) Solid-phase free radical (relative unit) 4-benzopyren e [a] (ng/ cigarette) NNK (ng/ cigarette) NNN (ng/ cigaret te) NAB (ng/ cigaret. te) NAT (ng/ cigarette)
No.1 8.73 8.31 14.50 5.50 9.09 1.07 11.74
No.2 6.08 5.60 9.80 3.30 3.01 0.43 6.53
Reduction rate (%) 30.36 32.61 32.41 40.00 66.89 59.81 44.38
Note: No.1 is the cigarette without biological composition (blank control cigarette); No.2 is the cigarette with biological composition, and mass ratio of cobalt porphyrin to ginkgo leaf extract: 1:3. NNK:4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone;NNN:N-nitrosonornicotine;NAB: N-nitrosoanabasine; NAT: N-nitrosoanatabine

d. Biological test
Toxicity of the blank control cigarette and the cigarette with the invented filter tip is tested, and the result proves that mutagenicity and toxicity of the latter are lower than those of the former.
(a) Salmonella typhimurium/ mammal microsome enzyme test (Ames test) Ames test results are listed in Table 2. Three doses from 100 to 500 in the table have inhibitory action, and the mutagenicity reduces. Table 2 Results of Sample Mutagenesis with Ames Test Incorporating Method (X+SD) (+S9)
Groups Tested tar dose (µg/vessel) Colony number of reverse mutation (number/vessel) Inhibition rate (%)
100 64.8±11.8
No.1 300 83.2±12.0
500 107.2±9.7
100 42.8±10.0 49.66
No.2 300 53.2±9.8 47.85
500 70.4±10.5 42.45
Solvent+S9 20.5±2.4

(b) Acute toxicity test of passive smoking and observation of pulmomary histopathology of mice
Reaction of mice during the test is detailed in the following. The mouse smoking No.1 cigarette is excited and active for the first ten cigarettes and then quiet. In the process of smoking, its ears, mouth, toes and tail are subject to hyperemia, and it scurries about and twitches before death. But the mouse smoking No.2 cigarette has longer quiet time, delayed death and calm breath, while hyperemia of its ears, mouth, nose, throat, toes and tail is less obvious than that of the mouse smoking No.1. Survival rate, median lethal dose and lethal dose for the cigarette with the invented filter tip are higher than those of the blank control cigarette, and smoke toxicity of the former also reduces (Table 3). Table 3 Results of Acute Toxicity of the Mouse with Passive Smoking
Group s Number of tested mice Survival rate (%) Median lethal dose(cig) Lethal dose(cig)
No.1 60 33.3 49 35
No.2 60 40.0 54 44
After the acute toxicity test of passive smoking is completed, histopathology of mice is observed. Lung tissues and small veins of 100% mice smoking the blank control cigarette and only 46.7% mice smoking the cigarette with the invented filter tip are subject to hyperemia.
(c) Toxicity test of neutrophil erythrocyte
According to Table 4, median lethal dose of tar for No.1 and No.2 is 141.42µg/ml and 213.35µg/ml respectively, so cytotoxicity of tar in the invented filter tip is much lower than that of the blank control group. Table 4 Test Results of Neutrophil Erythrocyte Toxicity
Groups Median lethal dose (LD50,µg/ml)
No.1 141.42
No.2 213.35

(d) Subchronic toxicity test
The rats are weighted by balance respectively after passive smoking for 30 days. Three groups, including the negative control, are not found obvious weight changes and not reach the significance level. Then rats are killed to obtain their respiratory tract and lung for pathology observation. It is found that periacinar emphysema of rats smoking No.1 cigarette is serious while that smoking No. 2 cigarette is mild. Sternum marrow of rats, whose blood samples are taken, is collected for micronucleus test, and the test results are shown in the Table 5. The tar-induced micronucleus frequency of the blank control group, No. 1 Group and No.2 Group is 2.33‰, 5.00‰ and 3.92‰ respectively. Compared with the blank control, the positive result is reached, but there is no significant difference between No.1 and No.2. That is to say, no new toxicity and side effects appear after the biological composition is added into the filter tip which can alleviate injury of lung to a certain degree. Table 5 Frequencies of Micronucleated Polychromatic Erythrocytes in Mouse Bone Marrow
Groups Number of Cell observed Number of micronuclei Micronuclear rates (‰)
Blank group (negative control) 12000 28 2.33
No.1 12000 60 5.00
No.2 12000 47 3.92
Description of Figures
  • Test results of this invention and structural representation of filter tip are described in the following.
    • Figure 1 is the spectrogram on interaction of porphyrins and benzopyrene, Ksv = (5.27 ± 0.31) x 105.
    • Figure 2 is the spectrogram on interaction of porphyrins and TSNAs, (A), (B), (C) and (D) are the spectrogram on interaction with NNN, NAB, NNK and NAT respectively, of which B-H and B-L are spectrum curves for NNN, NAB, NNK and NAT with increasing concentration in cobalt porphyrin.
    • Figure 3 is the structural representation of dual composite filter.
    Mode of Carrying Out The Invention
  • This invention will be further specified with Figure 3 in the following.
  • The dual composite filter in this invention consists of tow filter rod 1 (the biological composition adheres to the carrier, and then such carrier is added evenly to the tow filter rod when the rod is made.), tow filter rod without biological composition 2, inner coil paper 3 and outer coil paper 4, and its main characteristic is that the carrier with biological composition is added evenly to the tow filter rod.
  • This invention is achieved in this way:
  • A certain amount of cobalt porphyrin and ginkgo leak extract is dissolved in 95% ethanol, and polyvinylpyrrolidone is added and mixed up. The solution in a certain proportion adheres to the carrier and then evenly added to the tow filter rod 1 to get the dual composite filter.
  • In detail: mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼80, 1:1∼50 (better), 1:1∼30 (much better), or 1:1∼10 (best).
  • In detail: the ratio of biological composition to ethanol is 1g biological composition: 10-100ml ethanol, 1g biological composition: 10-50ml ethanol (better), or 1g biological composition: 10-20ml ethanol (best).
  • In detail: mass ratio of polyvinylpyrrolidone to biological composition is 1:1∼50, 1:1∼20 (better), or 1:1∼10 (best).
  • In detail: the carrier is active carbon, green plant particle and silicate.
  • In detail: the ratio of mass of the biological composition to the carrier is 0.1‰∼5.0‰.
  • In detail: the addition of the carrier with biological composition added to the tow filter rod is 3-30mg/cigarette.
  • In detail: the adding method is that the carrier with biological composition falls to the tow filter rod so as to control quantity of the barrier.
  • In detail: the tow filter rod may be acetate tow, polypropylene tow, or made of other materials.
  • In detail: the carrier with biological composition is evenly added when the tow filter rod is made. The tow filter rod 1 with biological composition and tow filter rod 2 without biological composition respectively are made by inner coil paper 3. On the composite filter maker, two rods are made into the dual composite filter by outer coil paper 4.
  • Finally, the dual composite filter integrates by cork with the cut tobacco wrapped by coil paper on cigarette maker, and the rod 1 is placed between the rod 2 and cut tobacco.
  • Cobalt porphyrin used in this invention, at the content of 96%, is purchased from ALFA, while ginkgo leaf extract, containing 24% flavone and 6% lactone, is purchased from Ningbo Liwah Pharmaceutical CO.,LTD.
  • The technical scheme described above and the specific processing steps listed in the following for preparing the dual composite filter are also applicable to the multiple composite filter made from many filter rods.
  • Implementation Example: 5.0g cobalt porphyrin and 15.0g ginkgo leaf extract are weighed and dissolved in 400ml 95% ethanol, besides, added with 5g polyvinylpyrrolidone, mixed up, and which adheres to 40kg carrier. Then such carrier of 6mg/cigarette is added to the tow filter rod to make the dual composite filter, and the cigarette is made. Results of sensory evaluation, harmful ingredients test in smoke and biological test prove that the cigarette with the invented filter tip is characterized in consistent smoke well, reduced stimulation and tasty flavor; effect of releasing quantity decrease of harmful ingredients in smoke and biological test conform to the invention descriptions.
  • The above implementation scheme has expounded this invention, but other implementation schemes are also possible. Consequently, nature and scope of the Claims should not be limited to descriptions of this implementation scheme in the present disclosure.
  • Claims (10)

    1. A type of composite filter tips containing biological composition, which is characterized in that the biological composition adheres to the carrier, which is added to the tow filter rod when the rod is made.
    2. A type of composite filter tips containing biological composition according to Claim 1, which is characterized in that it is the dual composite filter which is made from the tow filter rod with biological composition and that without biological composition.
    3. A type of composite filter tips containing biological composition according to Claim 1, which is characterized in that the biological composition consists of cobalt porphyrin and ginkgo leaf extract.
    4. A type of composite filter tips containing biological composition according to Claim 3, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼80; ratio of mass of the biological composition to the carrier is 0.1‰∼5.0‰; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
    5. A type of composite filter tips containing biological composition according to Claim 4, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼50.
    6. A type of composite filter tips containing biological composition according to Claim 5, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼10.
    7. The methods of preparing the composite filter tip containing biological composition, including the following steps:
      (1) The biological composition of cobalt porphyrin and ginkgo leak extract is prepared and dissolved in ethanol. In addition, the polyvinylpyrrolidone is added to the ethanol solution containing biological composition and mixed up.
      (2) The mixture in Step (1) adheres to the carrier.
      (3) The carrier in Step (2) is added evenly when tow filter rod is made.
      (4) Then the tow filter rod with the composition and one without the composition are rolled with the inner coil paper respectively
      (5) Finally, tow filter rods are made into the filter tip with outer coil paper on the composite filter tip maker.
    8. A method of preparing the composite filter tip according to Claim 7, which is characterized in that the biological composition consists of cobalt porphyrin and ginkgo leaf extract; mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼80; mass ratio of the biological composition to the carrier is 0.1‰∼5.0‰; the addition of the carrier with biological composition in the tow filter rod is 3-30mg/cigarette.
    9. A method of preparing the composite filter tip according to Claim 8, which is characterized in that mass ratio of cobalt porphyrin to ginkgo leaf extract is 1:1∼10.
    10. The composite filter tip containing biological composition according to Claim 1-9 is applied to the cigarette.
    EP10838536.0A 2009-12-23 2010-04-13 Composite filter comprising biological composition Active EP2517584B1 (en)

    Priority Applications (2)

    Application Number Priority Date Filing Date Title
    CN2009102635484A CN101708072B (en) 2009-12-23 2009-12-23 Composite filter tip containing biological composition
    PCT/CN2010/071732 WO2011075970A1 (en) 2009-12-23 2010-04-13 Composite filter comprising biological composition

    Publications (3)

    Publication Number Publication Date
    EP2517584A1 true EP2517584A1 (en) 2012-10-31
    EP2517584A4 EP2517584A4 (en) 2013-12-25
    EP2517584B1 EP2517584B1 (en) 2015-09-02

    Family

    ID=42400898

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP10838536.0A Active EP2517584B1 (en) 2009-12-23 2010-04-13 Composite filter comprising biological composition

    Country Status (3)

    Country Link
    EP (1) EP2517584B1 (en)
    CN (1) CN101708072B (en)
    WO (1) WO2011075970A1 (en)

    Cited By (1)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    CN104026732A (en) * 2014-06-13 2014-09-10 广西中烟工业有限责任公司 Tobacco leaf and glutinous rice flour composite particle preparation method and aroma enhancement application of tobacco leaf and glutinous rice flour composite particle to filter tip

    Families Citing this family (5)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    CN102697183B (en) * 2012-06-15 2014-02-26 川渝中烟工业有限责任公司 Cigarette filter additive with harm reduction effect and preparation method and application thereof
    CN102715654B (en) * 2012-06-15 2014-02-26 川渝中烟工业有限责任公司 Filter additive for reducing nitrosamines in cigarette smoke and application of filter additive
    CN105167190B (en) * 2015-06-17 2018-10-09 湖北中烟工业有限责任公司 Cigarette is with flavones essence cigarette pearl and preparation method thereof
    CN108013505A (en) * 2017-12-06 2018-05-11 湖北中烟工业有限责任公司 A kind of method of bionical ferroheme and synthesis and preparation containing the bionical ferroheme mouth rod
    CN108576921B (en) * 2018-03-21 2021-02-02 云南中烟工业有限责任公司 Composite material for reducing phenol release amount in smoke and preparation method and application thereof

    Citations (8)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    WO1998015197A1 (en) * 1996-05-15 1998-04-16 Craig Lesser Tobacco smoke filter for removing toxic compounds
    CN1252245A (en) * 1999-11-23 2000-05-10 郭灿城 Biological tobacco tar reducing agent
    DE10009829A1 (en) * 2000-03-01 2001-09-20 Reemtsma H F & Ph Filter cigarette has two part filter with ventilator, core, casing and length of tobacco.
    EP0720434B1 (en) * 1994-06-27 2002-01-23 Golden Filter SA Removal of noxious oxidants and carcinogenic volatile nitrosocompounds from cigarette smoke using biological substances
    WO2003013285A1 (en) * 2001-07-25 2003-02-20 Chu-Whan Cho A filtering material for cigarette and its process to use ginkgo leaf ingredients
    WO2003053179A1 (en) * 2001-12-21 2003-07-03 Filtrona Italia S.P.A. Cigarette filters containing lipophile flavonoids and/or tocopherols and tocotrienols
    WO2007121439A2 (en) * 2006-04-17 2007-10-25 Filligent Limited Method and device for making tobacco smoke filters
    CN100431435C (en) * 2005-10-26 2008-11-12 重庆烟草工业有限责任公司 Use of four kinds of porphyrin compounds to remove carcinogenic substances from smoke of cigarette

    Family Cites Families (2)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    CN1650763A (en) * 2005-02-24 2005-08-10 冷博 Tar harm reducing type cigarette and its preparation method
    CN2909862Y (en) * 2006-05-15 2007-06-13 牡丹江卷烟材料厂有限责任公司 Two-element composite filter-tip made of paper, active carbon and acetate fiber

    Patent Citations (8)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    EP0720434B1 (en) * 1994-06-27 2002-01-23 Golden Filter SA Removal of noxious oxidants and carcinogenic volatile nitrosocompounds from cigarette smoke using biological substances
    WO1998015197A1 (en) * 1996-05-15 1998-04-16 Craig Lesser Tobacco smoke filter for removing toxic compounds
    CN1252245A (en) * 1999-11-23 2000-05-10 郭灿城 Biological tobacco tar reducing agent
    DE10009829A1 (en) * 2000-03-01 2001-09-20 Reemtsma H F & Ph Filter cigarette has two part filter with ventilator, core, casing and length of tobacco.
    WO2003013285A1 (en) * 2001-07-25 2003-02-20 Chu-Whan Cho A filtering material for cigarette and its process to use ginkgo leaf ingredients
    WO2003053179A1 (en) * 2001-12-21 2003-07-03 Filtrona Italia S.P.A. Cigarette filters containing lipophile flavonoids and/or tocopherols and tocotrienols
    CN100431435C (en) * 2005-10-26 2008-11-12 重庆烟草工业有限责任公司 Use of four kinds of porphyrin compounds to remove carcinogenic substances from smoke of cigarette
    WO2007121439A2 (en) * 2006-04-17 2007-10-25 Filligent Limited Method and device for making tobacco smoke filters

    Non-Patent Citations (4)

    * Cited by examiner, † Cited by third party
    Title
    DING X P ET AL: "Quality control of flavonoids in Ginkgo biloba leaves by high-performance liquid chromatography with diode array detection and on-line radical scavenging activity detection", JOURNAL OF CHROMATOGRAPHY, vol. 1216, no. 11, 13 March 2009 (2009-03-13), pages 2204-2210, XP025992541, ELSEVIER SCIENCE PUBLISHERS B.V, NL ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2008.08.115 [retrieved on 2008-09-05] *
    Folttmann H., Quadir A.: "Polyvinylpyrrolidone (PVP) One of the Most Widely UsedExcipients in Pharmaceuticals: An Overview", Drug Delivery Technology Drug Delivery Technology, vol. 8, no. 6 June 2008 (2008-06), pages 22-27, XP002715956, Retrieved from the Internet: URL:http://www.pharma-ingredients.basf.com/Documents/ENP/Review%20Articles/DDT-June-2008.pdf [retrieved on 2013-11-06] *
    General Aniline & Film Corporation: "Method for preparation of plug tobacco from smoking articles consisting of tobacco, with reduced undesirable properties", Legacy Tobacco Documents Library University of California, San Francisco, 27 March 2006 (2006-03-27), XP002715958, Retrieved from the Internet: URL:http://legacy.library.ucsf.edu/tid/uie16a99/pdf [retrieved on 2013-11-06] *
    See also references of WO2011075970A1 *

    Cited By (2)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    CN104026732A (en) * 2014-06-13 2014-09-10 广西中烟工业有限责任公司 Tobacco leaf and glutinous rice flour composite particle preparation method and aroma enhancement application of tobacco leaf and glutinous rice flour composite particle to filter tip
    CN104026732B (en) * 2014-06-13 2017-01-04 广西中烟工业有限责任公司 The preparation method of a kind of Nicotiana tabacum L. glutinous rice flour composite particles and the flavouring application in filter tip thereof

    Also Published As

    Publication number Publication date
    CN101708072B (en) 2011-04-13
    WO2011075970A1 (en) 2011-06-30
    EP2517584A4 (en) 2013-12-25
    EP2517584B1 (en) 2015-09-02
    CN101708072A (en) 2010-05-19

    Similar Documents

    Publication Publication Date Title
    EP2517584B1 (en) Composite filter comprising biological composition
    US7025067B2 (en) Activated charcoal filter for effectively reducing p-benzosemiquinone from the mainstream cigarette smoke
    RU2010545C1 (en) Cigarette filter
    JP5832991B2 (en) Cigarette filter
    CN103892464A (en) Poison-reducing body-building cigarette filter
    JP5161585B2 (en) Cigarette with filter
    KR100964503B1 (en) Cucurbituril added cigarettes and manufacturing method thereof
    KR100890583B1 (en) Use of polyphenol compounds as scavengers of free radicals in cigarette filters
    CN101141891B (en) Instant tip rod appended solution when sucking cigarette and producing method and application
    CN111035057A (en) Method for preparing tar extract from waste cigarette butts and application of tar extract in cigarettes
    EP2937001A1 (en) Aluminosilicate sab-15 as an additive for reducing the toxic and carcinogenic compounds present in tobacco smoke
    CN106083781B (en) A kind of benzo lactone preparation method and applications with cigarette flavouring effect
    RU91815U1 (en) Filter for cigarettes
    EP2098129A1 (en) Method for production of tobacco leaf
    RU2045921C1 (en) Cigarette filter
    KR102288257B1 (en) Functional cigarette filter comprising natural plant material, cigarette containing the same, and method for producing the same
    CN103783661B (en) A kind of method extracting essence spice for cigarette from cigar mill's processing waste gas
    CN111035053A (en) Method for extracting aroma components from cigarette end tar and application of aroma components in cigarettes
    RU50845U1 (en) Composite cigarette filter
    CN108272129A (en) A kind of preparation method of the cigarette with protective effect on cancer risk

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    17P Request for examination filed

    Effective date: 20120202

    AK Designated contracting states

    Kind code of ref document: A1

    Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

    DAX Request for extension of the european patent (deleted)
    RAP1 Party data changed (applicant data changed or rights of an application transferred)

    Owner name: CHINA TOBACCO CHUANYU INDUSTRIAL CO., LTD

    RIC1 Information provided on ipc code assigned before grant

    Ipc: A24B 15/20 20060101ALI20131108BHEP

    Ipc: A24D 3/02 20060101ALI20131108BHEP

    Ipc: A24D 3/06 20060101AFI20131108BHEP

    Ipc: A24B 15/28 20060101ALI20131108BHEP

    Ipc: A24B 15/16 20060101ALI20131108BHEP

    RIC1 Information provided on ipc code assigned before grant

    Ipc: A24B 15/20 20060101ALI20131119BHEP

    Ipc: A24B 15/28 20060101ALI20131119BHEP

    Ipc: A24B 15/16 20060101ALI20131119BHEP

    Ipc: A24D 3/06 20060101AFI20131119BHEP

    Ipc: A24D 3/02 20060101ALI20131119BHEP

    RIN1 Information on inventor provided before grant (corrected)

    Inventor name: WANG, CHANGGUO

    Inventor name: DAI, YA

    A4 Supplementary search report drawn up and despatched

    Effective date: 20131126

    GRAP Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOSNIGR1

    INTG Intention to grant announced

    Effective date: 20150330

    GRAS Grant fee paid

    Free format text: ORIGINAL CODE: EPIDOSNIGR3

    GRAA (expected) grant

    Free format text: ORIGINAL CODE: 0009210

    AK Designated contracting states

    Kind code of ref document: B1

    Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: FG4D

    REG Reference to a national code

    Ref country code: AT

    Ref legal event code: REF

    Ref document number: 745969

    Country of ref document: AT

    Kind code of ref document: T

    Effective date: 20150915

    Ref country code: CH

    Ref legal event code: EP

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: FG4D

    REG Reference to a national code

    Ref country code: DE

    Ref legal event code: R096

    Ref document number: 602010027274

    Country of ref document: DE

    REG Reference to a national code

    Ref country code: AT

    Ref legal event code: MK05

    Ref document number: 745969

    Country of ref document: AT

    Kind code of ref document: T

    Effective date: 20150902

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: FI

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: LV

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: NO

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20151202

    Ref country code: LT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    REG Reference to a national code

    Ref country code: LT

    Ref legal event code: MG4D

    Ref country code: NL

    Ref legal event code: MP

    Effective date: 20150902

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: SE

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: ES

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: PL

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: AT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: SK

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: NL

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: EE

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: IS

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20160102

    Ref country code: CZ

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: IT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: RO

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    REG Reference to a national code

    Ref country code: DE

    Ref legal event code: R097

    Ref document number: 602010027274

    Country of ref document: DE

    REG Reference to a national code

    Ref country code: GR

    Ref legal event code: EP

    Ref document number: 20150402567

    Country of ref document: GR

    Effective date: 20160219

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

    26N No opposition filed

    Effective date: 20160603

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: SI

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: BE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160430

    Ref country code: DK

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: PL

    GBPC Gb: european patent ceased through non-payment of renewal fee

    Effective date: 20160413

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: LU

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20160413

    Ref country code: BE

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: MM4A

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: ST

    Effective date: 20161230

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: CH

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160430

    Ref country code: LI

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160430

    Ref country code: FR

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160502

    Ref country code: GB

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160413

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: IE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160413

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: SM

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: HU

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

    Effective date: 20100413

    Ref country code: CY

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: PT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: MT

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20160430

    Ref country code: HR

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: MC

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: TR

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    Ref country code: MK

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: BG

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20150902

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: GR

    Payment date: 20210420

    Year of fee payment: 12

    Ref country code: DE

    Payment date: 20210324

    Year of fee payment: 12